Who Just RaisedStrella Biotechnology, Inc.
Seattle, WA ยท Biotechnology
Strella Biotechnology, Inc. is a biotechnology company based in Seattle, Washington. In a Form D filed with the SEC on August 14, 2026, it reported raising $1,761,591 from 35 investors as part of an offering of up to $3,250,000. The first sale in the offering took place on June 29, 2026.
- Amount raised
- $1,761,591
- Offering size
- $3,250,000
- Investors so far
- 35
- First sale
- June 29, 2026
- Securities offered
- Equity, Options or warrants
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Seattle, Washington
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $1,761,591 | $3,250,000 | 35 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Other health care raises in Washington
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Q-Immune, Inc. | Seattle, WA | Health Care | $25K | $1M | |
| Seattle Neurosound Solutions, Inc. | Seattle, WA | Health Care | $100K | $5M | |
| Hexamer Therapeutics, Inc | Pullman, WA | Health Care | $500K | $2.5M | |
| DexCare, Inc. | Seattle, WA | Health Care | $12.9M | $22.7M | |
| Aptevo Therapeutics Inc. | Seattle, WA | Health Care | $3.5M | $3.5M | |
| MalarVx, Inc. | Seattle, WA | Health Care | $125K | $2.5M |